REMODULIN

Manufacturer:

United Therapeutics

Name:

REMODULIN

HCPCS Code Descriptor:

Injection, treprostinil, 1 mg

Category:

J Code

HCPCS:

J3285

NDC(s):

66302-0101-01, 66302-0102-01, 66302-0110-01, 66302-0105-01, 43598-0648-11, 43598-0649-11, 43598-0647-11, 43598-0646-11, 42023-0208-01, 42023-0209-01, 42023-0207-01, 42023-0206-01, 00781-3427-80, 00781-3430-80, 00781-3425-80, 00781-3420-80, 00703-0696-01, 00703-0686-01, 00703-0676-01, 00703-0666-01

Primary Type:

Cardiology

Generic Status:

Multi-Source

Route of Administration:

Injection

About:

REMODULIN is a Cardiology drug manufactured by United Therapeutics and administered via the Injection route of administration. The J Code: J3285 is aligned to the drug REMODULIN.

Remodulin belongs to the group of medications known as vasodilators. Remodulin works by dilating the blood vessels in the lungs and helps to mitigate the symptoms of high blood pressure. Remodulin is administered via subcutaneous infusion or an intravenous infusion. Remodulin is a generic drug that is manufactured by Sicor Pharmaceuticals, Sandoz, and Par Pharmaceutical Incorporated. Patient assistance programs for this medication can be found through United Therapeutics.